Lab testing for custom monoclonal recombinant antibodies generated through hucal technology (ambis 2222834)

Closed Pre-Solicitation Posted

Solicitation number
NOI-NIAID-24-2222834
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to procure lab testing services for custom monoclonal recombinant antibodies generated through HuCAL technology. The lab will send samples to the vendor, Bio-Rad AbD Serotec GmbH, for testing against the patented technology, and the results will be provided. The purpose of this procurement is for lab testing services, where lab-synthesized antibodies will be sent to Bio-Rad to generate monoclonal recombinant antibodies through their patented Human Combinatorial Antibody Libraries (HuCAL) technology. The lab will use these antibodies for in vitro studies including IHC (immunohistochemistry) studies.

This procurement will be awarded on an other than full and open competition basis to Bio-Rad AbD Serotec GmbH, as the statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1, indicating that there is only one responsible source and no other supply of service will satisfy agency requirements. The delivery timeline is immediate with a 3-month lead time, and the delivery location is NIH/NIAID/LCIM, 33 North Drive, Bethesda, MD 20892. The contract will be a firm-fixed price type.

Notice text

This is a Notice of Intent, not a request for proposal.  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Bio-Rad AbD Serotec GmbH, Campus Neuried, Anna-Sigmund-Str. 5, 82061, Neuried, Germany, to procure lab testing services for custom monoclonal recombinant antibodies generated through HuCAL technology.  The lab will send samples to the vendor, testing against the patented technology, and results will be provided.

The purpose of this procurement is for lab testing services.  Lab synthesized antibodies will be sent to Bio-Rad, who will generate monoclonal recombinant antibodies through a patented technology, Human Combinatorial Antibody Libraries (HuCAL), a technology which Bio-Rad custom antibody generation service uses for the in vitro generation of highly specific, fully human, recombinant monoclonal antibodies in Fab and full immunoglobulin format. The lab will use these antibodies for in vitro studies including IHC (immunohistochemistry) studies.

Our lab will be sending lab-synthesized/lab-developed antigens to the antibody manufacturer.  With the antigens, the antibody manufacturer will generate monoclonal recombinant antibodies and send it back to us. 

These antibodies will be used in our lab for in-vitro studies:

  1. CAB11586 - FAB PACKAGE, Antibody selection using a single customer provided antigen QC by specificity ELISA with purified antibodies, Delivery of 500 µI (~100-250 µg) each of all unique ELISA positive, purified Fab antibodies (max. 20), qty 1
  2. CAB11447 - SPECIAL PROJECT, Competition Primary Screen, quantity 1
  3. CAB11447 - SPECIAL PROJECT, Competition QC ELISA (Final QC), quantity 1
  4. CAB11577 - INHIBITION ELISA (with Titration), quantity 1
  5. CAB11447 - SPECIAL PROJECT, Handling of toxins, quantity 1
  6. CAB11631 - FCCATCHER COUPLING MULTIPLE FABS FcCatcher Coupling Multiple - up to 20 Antibodies, -100-250 ug each; (includes Fab production) (for sco), quantity 1
  7. CAB11664 - CATCHER FLUORESCENT FAB, Fluorescent Coupling Catchers max 250 ug, quantity 1
  8. CAB11457 - SHIPPING AND HANDLING (USA), quantity 1

Only one award will be made as a result of this solicitation.  This will be awarded as a firm-fixed price type of contract.

Delivery:

Immediate, 3 months lead time

Delivery location:

Service shall be performed at the following location: NIH/NIAID/LCIM, 33 North Drive, Bethesda, MD 20892.

The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS.  All responsible sources that could provide the required services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-24-2222834 to Rita Davis at rita.davis@nih.gov, by 4:00pm eastern standard time Tuesday, May 28, 2024.  All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Similar open opportunities

Opportunity Agency Set-aside Responses due
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
Pre-Clinical Models of Infectious Diseases United States · NAICS 541714 National Institute of Allergy and Infectious Diseases No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity